Gradl; Stefan Nikolaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gradl; Stefan Nikolaus.The latest application filed is for "2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh".

Company Profile

9.6.11

Gradl; Stefan Nikolaus - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dihydrooxadiazinones Grant 11,427,553 - Ellermann , et al. August 30, 2	2022-08-30
Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone Grant 11,365,179 - Hassfeld , et al. June 21, 2	2022-06-21
2,4,5-trisubstituted 1,2,4-triazolones Useful As Inhibitors Of Dhodh App 20220135536 - GRADL; Stefan Nikolaus ; et al.	2022-05-05
1,2,4-triazin-3(2h)-one Compounds For The Treatment Of Hyperproliferative Diseases App 20210353630 - GRADL; Stefan Nikolaus ; et al.	2021-11-18
4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides Grant 11,161,825 - Weiske , et al. November 2, 2	2021-11-02
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH Grant 11,130,745 - Gradl , et al. September 28, 2	2021-09-28
4,5-annulated 1,2,4-triazolones App 20210188846 - GRADL; Stefan Nikolaus ; et al.	2021-06-24
2,4,5-trisubstituted 1,2,4-triazolones Useful As Inhibitors Of Dhodh App 20210188805 - GRADL; Stefan Nikolaus ; et al.	2021-06-24
4,5-annulated 1,2,4-triazolones Grant 10,968,216 - Gradl , et al. April 6, 2	2021-04-06
Method For The Preparation Of A 2,4,5-trisubstituted 1,2,4-triazolone App 20210032212 - Hassfeld; Jorma ; et al.	2021-02-04
2,4,5-trisubstituted 1,2,4-triazolones Useful As Inhibitors Of Dhodh App 20200377472 - GRADL; Stefan Nikolaus ; et al.	2020-12-03
Dihydrooxadiazinones App 20200369633 - Ellermann; Manuel ; et al.	2020-11-26
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH Grant 10,815,215 - Gradl , et al. October 27, 2	2020-10-27
6-phenyl-4,5-dihydropyridazin-3(2h)-one Derivatives As Pde3a And Pde3b Inhibitors For Treating Cancer App 20200247783 - Kind Code	2020-08-06
4-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-7-carboxamides App 20200199083 - WEISKE; Jorg ; et al.	2020-06-25
2,4,5-trisubstituted 1,2,4-triazolones Useful As Inhibitors Of Dhodh App 20200123129 - GRADL; Stefan Nikolaus ; et al.	2020-04-23
4,5-annulated 1,2,4-triazolones App 20190375747 - GRADL; Stefan Nikolaus ; et al.	2019-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.